TrialNature cancer2026

Neoadjuvant PD-1 blockade in surgically resectable desmoplastic melanoma: cohort A of the phase 2 SWOG S1512 trial.

Kari L Kendra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.